Muller & Phipps (India) (BOM:501477) Margin of Safety % (DCF Dividends Based): N/A (As of Jul. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:501477 Muller & Phipps (India) Ltd BOM:501477
59 GF Score
Price ₹224.00
GF Value ₹281.72
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Muller & Phipps (India) Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

Muller & Phipps (India)'s Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Dividends Based) is not calculated.


Muller & Phipps (India) Margin of Safety % (DCF Dividends Based) Competitor Comparison

For the Pharmaceutical Retailers subindustry, Muller & Phipps (India)'s Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Muller & Phipps (India) Margin of Safety % (DCF Dividends Based) vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Muller & Phipps (India)'s Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where Muller & Phipps (India)'s Margin of Safety % (DCF Dividends Based) falls into.


BOM:501477
59GF Score
Muller & Phipps (India) Ltd BOM:501477
Margin of Safety % (DCF Dividends Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Muller & Phipps (India) (BOM:501477) Overvalued in 2026?

Based on GuruFocus' analysis, Muller & Phipps (India) stock appears to be undervalued. The current stock price of ₹224.00 is trading 20.5% below its estimated GF Value™ of ₹281.72. GuruFocus considers Muller & Phipps (India) to be Modestly Undervalued.

Key valuation signals for BOM:501477:

  • Margin of Safety % (DCF Dividends Based): N/A
  • GF Value™: ₹281.72 vs. price of ₹224.00 (20.5% below fair value)
  • GF Score™: 59/100 with 4 warning signs

No single metric tells the full story. See the BOM:501477 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Muller & Phipps (India) Business Description

Address 204, Madhva Commercial Premises, C-4, Bandra Kurla Complex, Bandra (East), Mumbai, MH, IND, 400051
Muller & Phipps (India) Ltd is engaged in the marketing of over-the-counter medical preparations and home care products. The operating segments of the company are Cosmetic/toiletry, Medicated preparation, Food Products, and Others, of which a majority of the revenue is derived from the Medical preparation segment. The company's product portfolio includes medicated dental products, ayurvedic skin ointment, and home care products. Its brand names include Cavisan, Cavidine, and Nixoderm.
59GF Score

Get the complete analysis for BOM:501477

Margin of Safety % (DCF Dividends Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹224.00
Price
₹281.72
GF Value